Commissioner Makary Charts a New Course for FDA at FDLI Annual Conference
FDA Law
MAY 15, 2025
Stage IV cancer should not be approved like a cosmetic, he quipped, quickly calling to mind his days as an oncological surgeon and the many difficult conversations he had with patients and families with very limited options. He also specifically mentioned rare diseases here , in addition to his example of late-stage illnesses.
59 
Let's personalize your content